SCHEMBL23745456

SCHEMBL23745456

Cc1cccc(C(CCNC2CCNCC2)c2cn(C3CCCCC3)c3ccccc23)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 2/20 0.50
HTR6 P50406 2/20 0.36
KDM4E B2RXH2 1/20 0.35
MPO P05164 4/20 0.34
MAPT P10636 2/20 0.33
PRKCG P05129 1/20 0.33
PRKCB P05771 1/20 0.33
PRKCA P17252 1/20 0.33
PRKCH P24723 1/20 0.33
PRKCE Q02156 1/20 0.33
PRKCZ Q05513 1/20 0.33
PRKCD Q05655 1/20 0.33
CAMK2B Q13554 1/20 0.33
CAMK2G Q13555 1/20 0.33
CAMK2D Q13557 1/20 0.33
CAMK2A Q9UQM7 1/20 0.33
SLC6A2 P23975 2/20 0.33
LMNA P02545 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23722150 0.99 SOS1 (0.49) SOS1HTR6KDM4EMPOMAPT
SCHEMBL23745826 0.99 SOS1 (0.51) SOS1HTR6KDM4EMPOMAPT
Hydrochloric Acid SCHEMBL23722094 0.98 SOS1 (0.50) SOS1HTR6KDM4EMPOMAPT
SCHEMBL23745580 0.95 SOS1 (0.50) SOS1HTR6MPOMAPTPRKCG
Hydrochloric Acid SCHEMBL23721946 0.95 SOS1 (0.49) SOS1HTR6MPOMAPTPRKCG
SCHEMBL23722039 0.90 SOS1 (0.43) SOS1HTR6MPOPRKCGPRKCB
SCHEMBL23745472 0.90 MPO (0.36) SOS1KDM4EMPOMAPTSLC6A2
SCHEMBL23745631 0.90 MPO (0.36) SOS1KDM4EMPOMAPTSLC6A2
Hydrochloric Acid SCHEMBL23722073 0.89 SOS1 (0.43) SOS1HTR6MPOPRKCGPRKCB
SCHEMBL23745754 0.89 SOS1 (0.36) SOS1KDM4EMPOMAPTSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 SOS1 2902/4885HTR6 4724/4885KDM4E 4474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.